Skip to main content
SpringerLink
Log in
Book cover

Dementia in Parkinsonism pp 111–120Cite as

Pathological diagnostic criteria for dementia associated with cortical Lewy bodies: review and proposal for a descriptive approach

  • Conference paper

Part of the book series: Journal of Neural Transmission. Supplementa ((NEURAL SUPPL,volume 51))

Summary

In recent years dementia histologically characterised by the presence of cortical Lewy bodies has been increasingly recognised. There is now need for a scheme for an internationally acceptable scheme for pathological diagnosis and classification so that clinical, pathological and molecular features of disease can be correlated. Recent observations made by different groups in large patient series have used slightly different pathological criteria resulting in at least seven different diagnostic terms. In some patients the only cortical pathology is the presence of Lewy bodies, while in the majority of patients there are coexisting pathological changes which either overlap with those seen in Alzheimer’s disease (AD). Cortical Lewy bodies can also be present in patients who do not have any obvious cognitive abnormality. A problem with equating studies from different groups is that different criteria have been used to define AD, so that establishing the relevance of cortical Lewy bodies themselves to cognitive decline and separating this from the contribution which may be related to the AD pathology is problematic. The lesions which appear to be of most relevance to potential cognitive decline in DLB are cortical Lewy bodies, Lewy-related neurites, senile plaques, neurofibrillary tangles, neuronal and synaptic loss, spongiform change, and cortical cholinergic deficits. It is possible to operationally classify patients with cognitive decline and cortical Lewy bodies into three main groups, Cortical Lewy body disease, Cortical Lewy body disease with plaques, and Cortical Lewy body disease with plaques and tangles. There are frequent cases which overlap these groups making operational classification difficult in practice. A descriptive classification, in which the severity of different pathological changes is rated, is easy to use in practice. As new molecular risk factors for AD or DLB are revealed they will need to be related to morphological and clinical features. A descriptive diagnostic assessment for DLB will facilitate such studies and makes no judgements as to what these relationships will be.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Armstrong TP, Hansen LA, Salmon DP, Masliah E, et al. (1991) Rapidly progressive dementia in a patient with the Lewy body variant of Alzheimer’s disease. Neurology 41(8): 1178–1180.

    Article  PubMed  CAS  Google Scholar 

  • Bancher C, Braak H, Fischer P, Jellinger KA (1993) Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer’s and Parkinson’s disease patients. Neurosci Lett 162(1–2): 179–182.

    Article  PubMed  CAS  Google Scholar 

  • Benjamin R, Leake A, Edwardson JA, McKeith IG, et al. (1994) Apolipoprotein E genes in Lewy body and Parkinson’s disease. Lancet 343(8912): 1565.

    Article  PubMed  CAS  Google Scholar 

  • Betard C, Robitaille Y, Gee M, Tiberghien D, et al. (1994) Apo E allele frequencies in Alzheimer’s disease, Lewy body dementia, Alzheimer’s disease with cerebrovascular disease and vascular dementia. Neuroreport 5(15): 1893–1896.

    Article  PubMed  CAS  Google Scholar 

  • Bodhireddy S, Dickson DW, Mattiace L, Weidenheim KM (1994) A case of Down’s syndrome with diffuse Lewy body disease and Alzheimer’s disease. Neurology 44(1): 159–161.

    Article  PubMed  CAS  Google Scholar 

  • Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Beri) 82(4): 239–259.

    Article  CAS  Google Scholar 

  • Braak H, Braak E, Yilmazer D, de Vos RA, et al. (1994) Amygdala pathology in Parkinson’s disease. Acta Neuropathol (Beri) 88(6): 493–500.

    Article  CAS  Google Scholar 

  • Burkhardt CR, Filley CM, Kleinschmidt-De Masters BK, de la Monte S, et al. (1988) Diffuse Lewy body disease and progressive dementia. Neurology 38(10): 1520–1528.

    Article  PubMed  CAS  Google Scholar 

  • Byrne EJ, Lowe J, Godwin-Austen RB, Arie T, et al. (1987) Dementia and Parkinson’s disease associated with diffuse cortical Lewy bodies. Lancet i (8531): 501.

    Article  Google Scholar 

  • Byrne EJ, Lennox G, Lowe J, Godwin-Austen RB (1989) Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry 52(6): 709–717.

    Article  PubMed  CAS  Google Scholar 

  • Byrne E, Lennox G, Godwin-Austen R, Mayer R, et al. (1991) Diagnostic criteria for dementia associated with cortical Lewy bodies. Dementia 2: 283–284.

    Google Scholar 

  • Clark AW, White CLd, Manz HJ, Parhad IM, et al. (1986) Primary degenerative dementia without Alzheimer pathology. Can J Neurol Sci 13 [4 Suppl]: 462–470.

    PubMed  CAS  Google Scholar 

  • Crystal HA, Dickson DW, Lizardi JE, Davies P, et al. (1990) Antemortem diagnosis of diffuse Lewy body disease. Neurology 40(10): 1523–1528.

    Article  PubMed  CAS  Google Scholar 

  • de Bruin VM, Lees AJ, Daniel SE (1992) Diffuse Lewy body disease presenting with supranuclear gaze palsy, parkinsonism, and dementia: a case report. Mov Disord 7(4): 355–358.

    Article  PubMed  Google Scholar 

  • de Vos RA, Jansen EN, Stam FC, Ravid R, et al. (1995) “Lewy body disease”: clinico-pathological correlations in 18 consecutive cases of Parkinson’s disease with and without dementia. Clin Neurol Neurosurg 97(1): 13–22.

    Article  PubMed  Google Scholar 

  • Dickson DW, Davies P, Mayeux R, Crystal H, et al. (1987) Diffuse Lewy body disease. Neuropathological and biochemical studies of six patients. Acta Neuropathol (Berl) 75(1): 8–15.

    Article  CAS  Google Scholar 

  • Dickson DW, Crystal H, Mattiace LA, Kress Y, et al. (1989) Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques. Acta Neuropathol (Beri) 78(6): 572–584.

    Article  CAS  Google Scholar 

  • Dickson DW, Ruan D, Crystal H, Mark MH, et al. (1991) Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer’s disease: light and electron microscopic immunocytochemistry of CA2–3 neurites specific to DLBD. Neurology 41(9): 1402–1409.

    Article  PubMed  CAS  Google Scholar 

  • Dickson DW, Schmidt ML, Lee VM, Zhao ML, et al. (1994) Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease. Acta Neuropathol (Berl) 87(3): 269–276.

    Article  CAS  Google Scholar 

  • Duvoisin RC, Johnson WG (1992) Hereditary Lewy-body parkinsonism and evidence for a genetic etiology of Parkinson’s disease. Brain Pathol 2(4): 309–320.

    Article  PubMed  CAS  Google Scholar 

  • Eggertson DE, Sima AA (1986) Dementia with cerebral Lewy bodies. A mesocortical dopaminergic defect? Arch Neurol 43(5): 524–527.

    Article  PubMed  CAS  Google Scholar 

  • Fearnley JM, Revesz T, Brooks DJ, Frackowiak RS, et al. (1991) Diffuse Lewy body disease presenting with a supranuclear gaze palsy. J Neurol Neurosurg Psychiatry 54(2): 159–161.

    Article  PubMed  CAS  Google Scholar 

  • Gai WP, Blessing WW, Blumbergs PC (1995) Ubiquitin-positive degenerating neurites in the brainstem in Parkinson’s disease. Brain 118(6): 1447–1459.

    Article  PubMed  Google Scholar 

  • Galasko D, Saitoh T, Xia Y, Thal LJ, et al. (1994) The apolipoprotein E allele epsilon 4 is over-represented in patients with the Lewy body variant of Alzheimer’s disease. Neurology 44(10): 1950–1951.

    Article  PubMed  CAS  Google Scholar 

  • Gearing M, Mirra SS, Hedreen JC, Sumi SM, et al. (1995) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD), part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer’s disease. Neurology 45(3 Pt 1): 461–466.

    CAS  Google Scholar 

  • Gentleman SM, Williams B, Royston MC, Jagoe R, et al. (1992) Quantification of beta A4 protein deposition in the medial temporal lobe: a comparison of Alzheimer’s disease and senile dementia of the Lewy body type. Neurosci Lett 142(1): 9–12.

    Article  PubMed  CAS  Google Scholar 

  • Gibb WR, Esiri MM, Lees AJ (1987) Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 110(Pt 5): 1131–1153.

    Article  PubMed  Google Scholar 

  • Gibb WR, Luthert PJ, Janota I, Lantos PL (1989) Cortical Lewy body dementia: clinical features and classification. J Neurol Neurosurg Psychiatry 52(2): 185–192.

    Article  PubMed  CAS  Google Scholar 

  • Golbe LI (1993) The genetics of Parkinson’s disease. Rev Neurosci 4(1): 1–16.

    Article  PubMed  CAS  Google Scholar 

  • Hainfellner JA, Pilz P, Lassmann H, Ladurner G, et al. (1995) Diffuse Lewy body disease as substrate of primary lateral sclerosis. J Neurol 242(2): 59–63.

    Article  PubMed  CAS  Google Scholar 

  • Hansen LA, Masliah E, Terry RD, Mirra SS (1989) A neuropathological subset of Alzheimer’s disease with concomitant Lewy body disease and spongiform change. Acta Neuropathol (Berl) 78(2): 194–201.

    Article  CAS  Google Scholar 

  • Hansen L, Salmon D, Galasko D, Masliah E, et al. (1990) The Lewy body variant of Alzheimer’s disease: a clinical and pathologic entity. Neurology 40(1): 1–8.

    Article  PubMed  CAS  Google Scholar 

  • Hansen LA, Masliah E, Quijada-Fawcett S, Rexin D (1991) Entorhinal neurofibrillary tangles in Alzheimer disease with Lewy bodies. Neurosci Lett 129(2): 269–272.

    Article  PubMed  CAS  Google Scholar 

  • Hansen LA, Masliah E, Galasko D, Terry RD (1993) Plaque-only Alzheimer disease is usually the lewy body variant, and vice versa. J Neuropathol Exp Neurol 52(6): 648–654.

    Article  PubMed  CAS  Google Scholar 

  • Hansen LA, Galasko D, Samuel W, Xia Y, et al. (1994) Apolipoprotein-E epsilon-4 is associated with increased neurofibrillary pathology in the Lewy body variant of Alzheimer’s disease. Neurosci Lett 182(1): 63–65.

    Article  PubMed  CAS  Google Scholar 

  • Hardy J (1994) Lewy bodies in Alzheimer’s disease in which the primary lesion is a mutation in the amyloid precursor protein. Neurosci Lett 180 (2): 290–291.

    Article  PubMed  CAS  Google Scholar 

  • Hardy J, Crook R, Prihar G, Roberts G, et al. (1994) Senile dementia of the Lewy body type has an apolipoprotein E epsilon 4 allele frequency intermediate between controls and Alzheimer’s disease. Neurosci Lett 182(1): 1–2.

    Article  PubMed  CAS  Google Scholar 

  • Harrington CR, Louwagie J, Rossau R, Vanmechelen E, et al. (1994a) Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer’s disease. Am J Pathol 145(6): 1472–1484.

    CAS  Google Scholar 

  • Harrington CR, Perry RH, Perry EK, Hurt J, et al. (1994b) Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein. Dementia 5(5): 215–228.

    PubMed  CAS  Google Scholar 

  • Hughes AJ, Daniel SE, Blankson S, Lees AJ (1993) A clinicopathologic study of 100 cases of Parkinson’s disease. Arch Neurol 50(2): 140–148.

    Article  PubMed  CAS  Google Scholar 

  • Ince P, Irving D, MacArthur F, Perry RH (1991) Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson’s disease and non-demented elderly control patients. J Neurol Sci 106(2): 142–152.

    Article  PubMed  CAS  Google Scholar 

  • Jackson M, Lennox G, Balsitis M, Lowe J (1995) Lewy body dysphagia. J Neurol Neurosurg Psychiatry 58(6): 756–758.

    Article  PubMed  CAS  Google Scholar 

  • Kim H, Gearing M, Mirra SS (1995) Ubiquitin-positive CA2/3 neurites in hippocampus coexist with cortical Lewy bodies. Neurology 45(9): 1768–1770.

    Article  PubMed  CAS  Google Scholar 

  • Kosaka K (1990) Diffuse Lewy body disease in Japan. J Neurol 237(3): 197–204.

    Article  PubMed  CAS  Google Scholar 

  • Kosaka K (1993) Dementia and neuropathology in Lewy body disease. Adv Neurol 60: 456–463.

    PubMed  CAS  Google Scholar 

  • Kosaka K, Yoshimura M, Ikeda K, Budka H (1984) Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree — A new disease? Clin Neuropathol 3(5): 185–192.

    PubMed  CAS  Google Scholar 

  • Kosaka K, Iseki E, Odawara T (1994) Cerebral type of Lewy body disease — a case report. Neuropathology 16: 72–75.

    Google Scholar 

  • Kulisevsky J, Marti MJ, Ferrer I, Tolosa E (1988) Meige syndrome: neuropathology of a case. Mov Disord 3(2): 170–175.

    Article  PubMed  CAS  Google Scholar 

  • Lantos PL, Ovenstone IM, Johnson J, Clelland CA, et al. (1994) Lewy bodies in the brain of two members of a family with the 717 (Val to Ile) mutation of the amyloid precursor protein gene. Neurosci Lett 172(1–2): 77–79.

    Article  PubMed  CAS  Google Scholar 

  • Lennox G (1992) Lewy body dementia. Baillières Clin Neurol 1(3): 653–676.

    PubMed  CAS  Google Scholar 

  • Lennox G, Lowe J, Landon M, Byrne EJ, et al. (1989a) Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. J Neurol Neurosurg Psychiatry 52(11): 1236–1247.

    Article  PubMed  CAS  Google Scholar 

  • Lennox G, Lowe J, Morrell K, Landon M, et al. (1989b) Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease. J Neurol Neurosurg Psychiatry 52(1): 67–71.

    Article  PubMed  CAS  Google Scholar 

  • Lippa CF, Smith TW, Swearer JM (1994) Alzheimer’s disease and Lewy body disease: a comparative clinicopathological study [published erratum appears in Ann Neurol (1994) 35(3):380]. Ann Neurol 35(1): 81–88.

    Article  PubMed  CAS  Google Scholar 

  • Lippa CF, Smith TW, Saunders AM, Crook R, et al. (1995) Apolipoprotein E genotype and Lewy body disease. Neurology 45(1): 97–103.

    Article  PubMed  CAS  Google Scholar 

  • Lowe J (1994) Lewy bodies. In: Calne D (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 51–69.

    Google Scholar 

  • Mark MH, Sage JI, Dickson DW, Heikkila RE, et al. (1994) Meige syndrome in the spectrum of Lewy body disease. Neurology 44(8): 1432–1436.

    Article  PubMed  CAS  Google Scholar 

  • Mark M, Dickson D, Sage J, Duvoisin R (1996) The clinicopathologic spectrum of Lewy body disease. Adv Neurol 69: 315–318.

    PubMed  CAS  Google Scholar 

  • McKeith IG, Perry RH, Fairbairn AF, Jabeen S, et al. (1992) Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 22(4): 911–922.

    Article  PubMed  CAS  Google Scholar 

  • McKeith IG, Fairbairn AF, Bothwell RA, Moore PB, et al. (1994) An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 44(5): 872–877.

    Article  PubMed  CAS  Google Scholar 

  • Mirra SS, Heyman A, McKeel D, Sumi SM, et al. (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD), part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41(4): 479–486.

    CAS  Google Scholar 

  • Mori H, Yoshimura M, Tomonaga M, Yamanouchi H (1986) Progressive supranuclear palsy with Lewy bodies. Acta Neuropathol (Beri) 71(3–4): 344–346.

    Article  CAS  Google Scholar 

  • Olsson JE, Brunk U, Lindvall B, Eeg-Olofsson O (1992) Dopa-responsive dystonia with depigmentation of the substantia nigra and formation of Lewy bodies. J Neurol Sci 112(1–2): 90–95.

    Article  PubMed  CAS  Google Scholar 

  • Pellise A, Roig C, BarraquerBordas L, Ferrer I (1996) Abnormal, ubiquitinated cortical neurites in patients with diffuse Lewy body disease. Neurosci Lett 206(2–3): 85–88.

    Article  PubMed  CAS  Google Scholar 

  • Perry RH, Irving D, Blessed G, Fairbairn A, et al. (1990) Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 95(2): 119–139.

    CAS  Google Scholar 

  • Perry EK, Haroutunian V, Davis KL, Levy R, et al. (1994) Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer’s disease. Neuroreport 5(7): 747–749.

    Article  PubMed  CAS  Google Scholar 

  • Pollanen MS, Dickson DW, Bergeron C (1993) Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 52(3): 183–191.

    Article  PubMed  CAS  Google Scholar 

  • Saitoh T, Xia Y, Chen X, Masliah E, et al. (1995) The CYP2D6B mutant allele is over represented in the Lewy body variant of Alzheimer’s disease. Ann Neurol 37(1): 110–112.

    Article  PubMed  CAS  Google Scholar 

  • Samuel W, Galasko D, Masliah E, Hansen LA (1996) Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer’s disease. J Neuropathol Exp Neurol 55(1): 44–52.

    Article  PubMed  CAS  Google Scholar 

  • Sima AA, Clark AW, Sternberger NA, Sternberger LA (1986) Lewy body dementia without Alzheimer changes. Can J Neurol Sci 13 [4 Suppl]: 490–497.

    PubMed  CAS  Google Scholar 

  • St Clair D, Norman J, Perry R, Yates C, et al. (1994) Apolipoprotein E epsilon 4 allele frequency in patients with Lewy body dementia, Alzheimer’s disease and age matched controls. Neurosci Lett 176(1): 45–46.

    Article  PubMed  CAS  Google Scholar 

  • Wakabayashi K, Honer WG, Masliah E (1994) Synapse alterations in the hippocampal- entorhinal formation in Alzheimer’s disease with and without Lewy body disease. Brain Res 667(1): 24–32.

    Article  PubMed  CAS  Google Scholar 

  • Wu E, Lipton RB, Dickson DW (1992) Amyloid angiopathy in diffuse Lewy body disease. Neurology 42(11): 2131–2135.

    Article  PubMed  CAS  Google Scholar 

  • Yoshimura N, Yoshimura I, Asada M, Hayashi S, et al. (1988) Juvenile Parkinson’s disease with widespread Lewy bodies in the brain. Acta Neuropathol (Berl) 77(2): 213–218.

    CAS  Google Scholar 

  • Zhan SS, Beyreuther K, Schmitt HP (1993) Quantitative assessment of the synaptophysin immuno-reactivity of the cortical neuropil in various neurodegenerative disorders with dementia. Dementia 4(2): 66–74.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Laboratory Sciences, Division of Pathology, University of Nottingham Medical School, Queen’s Medical Centre, Nottingham, NG7 2UH, UK

    Prof. J. Lowe

  2. Neuropathology, Albert Einstein College of Medicine, New York, NY, USA

    D. Dickson

Authors
  1. Prof. J. Lowe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Dickson
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Parkinson’s Disease Society Brain Research Centre (Brain Bank), Institute of Neurology, London, UK

    S. E. Daniel  & A. J. Lees  & 

  2. Neurological Tissue Bank, Hospital Clinic, University of Barcelona, Spain

    F. F. Cruz-Sánchez

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag/Wien

About this paper

Cite this paper

Lowe, J., Dickson, D. (1997). Pathological diagnostic criteria for dementia associated with cortical Lewy bodies: review and proposal for a descriptive approach. In: Daniel, S.E., Cruz-Sánchez, F.F., Lees, A.J. (eds) Dementia in Parkinsonism. Journal of Neural Transmission. Supplementa, vol 51. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6846-2_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6846-2_9

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-82959-2

  • Online ISBN: 978-3-7091-6846-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation